Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 31,699 shares at $85.01 ($2.7M) on 2019-08-08, disclosed to the SEC on 2019-08-12.
Open-market sale of $2.7M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRK | SELL | 2026-02-06 | $4.6M | — | Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |